Cargando…

Large-scale analysis of human gene expression variability associates highly variable drug targets with lower drug effectiveness and safety

MOTIVATION: The effectiveness of drugs tends to vary between patients. One of the well-known reasons for this phenomenon is genetic polymorphisms in drug target genes among patients. Here, we propose that differences in expression levels of drug target genes across individuals can also contribute to...

Descripción completa

Detalles Bibliográficos
Autores principales: Simonovsky, Eyal, Schuster, Ronen, Yeger-Lotem, Esti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6735839/
https://www.ncbi.nlm.nih.gov/pubmed/30649201
http://dx.doi.org/10.1093/bioinformatics/btz023
_version_ 1783450420355530752
author Simonovsky, Eyal
Schuster, Ronen
Yeger-Lotem, Esti
author_facet Simonovsky, Eyal
Schuster, Ronen
Yeger-Lotem, Esti
author_sort Simonovsky, Eyal
collection PubMed
description MOTIVATION: The effectiveness of drugs tends to vary between patients. One of the well-known reasons for this phenomenon is genetic polymorphisms in drug target genes among patients. Here, we propose that differences in expression levels of drug target genes across individuals can also contribute to this phenomenon. RESULTS: To explore this hypothesis, we analyzed the expression variability of protein-coding genes, and particularly drug target genes, across individuals. For this, we developed a novel variability measure, termed local coefficient of variation (LCV), which ranks the expression variability of each gene relative to genes with similar expression levels. Unlike commonly used methods, LCV neutralizes expression levels biases without imposing any distribution over the variation and is robust to data incompleteness. Application of LCV to RNA-sequencing profiles of 19 human tissues and to target genes of 1076 approved drugs revealed that drug target genes were significantly more variable than protein-coding genes. Analysis of 113 drugs with available effectiveness scores showed that drugs targeting highly variable genes tended to be less effective in the population. Furthermore, comparison of approved drugs to drugs that were withdrawn from the market showed that withdrawn drugs targeted significantly more variable genes than approved drugs. Last, upon analyzing gender differences we found that the variability of drug target genes was similar between men and women. Altogether, our results suggest that expression variability of drug target genes could contribute to the variable responsiveness and effectiveness of drugs, and is worth considering during drug treatment and development. AVAILABILITY AND IMPLEMENTATION: LCV is available as a python script in GitHub (https://github.com/eyalsim/LCV). SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
format Online
Article
Text
id pubmed-6735839
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-67358392019-09-16 Large-scale analysis of human gene expression variability associates highly variable drug targets with lower drug effectiveness and safety Simonovsky, Eyal Schuster, Ronen Yeger-Lotem, Esti Bioinformatics Original Papers MOTIVATION: The effectiveness of drugs tends to vary between patients. One of the well-known reasons for this phenomenon is genetic polymorphisms in drug target genes among patients. Here, we propose that differences in expression levels of drug target genes across individuals can also contribute to this phenomenon. RESULTS: To explore this hypothesis, we analyzed the expression variability of protein-coding genes, and particularly drug target genes, across individuals. For this, we developed a novel variability measure, termed local coefficient of variation (LCV), which ranks the expression variability of each gene relative to genes with similar expression levels. Unlike commonly used methods, LCV neutralizes expression levels biases without imposing any distribution over the variation and is robust to data incompleteness. Application of LCV to RNA-sequencing profiles of 19 human tissues and to target genes of 1076 approved drugs revealed that drug target genes were significantly more variable than protein-coding genes. Analysis of 113 drugs with available effectiveness scores showed that drugs targeting highly variable genes tended to be less effective in the population. Furthermore, comparison of approved drugs to drugs that were withdrawn from the market showed that withdrawn drugs targeted significantly more variable genes than approved drugs. Last, upon analyzing gender differences we found that the variability of drug target genes was similar between men and women. Altogether, our results suggest that expression variability of drug target genes could contribute to the variable responsiveness and effectiveness of drugs, and is worth considering during drug treatment and development. AVAILABILITY AND IMPLEMENTATION: LCV is available as a python script in GitHub (https://github.com/eyalsim/LCV). SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online. Oxford University Press 2019-09-01 2019-01-14 /pmc/articles/PMC6735839/ /pubmed/30649201 http://dx.doi.org/10.1093/bioinformatics/btz023 Text en © The Author(s) 2019. Published by Oxford University Press. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Papers
Simonovsky, Eyal
Schuster, Ronen
Yeger-Lotem, Esti
Large-scale analysis of human gene expression variability associates highly variable drug targets with lower drug effectiveness and safety
title Large-scale analysis of human gene expression variability associates highly variable drug targets with lower drug effectiveness and safety
title_full Large-scale analysis of human gene expression variability associates highly variable drug targets with lower drug effectiveness and safety
title_fullStr Large-scale analysis of human gene expression variability associates highly variable drug targets with lower drug effectiveness and safety
title_full_unstemmed Large-scale analysis of human gene expression variability associates highly variable drug targets with lower drug effectiveness and safety
title_short Large-scale analysis of human gene expression variability associates highly variable drug targets with lower drug effectiveness and safety
title_sort large-scale analysis of human gene expression variability associates highly variable drug targets with lower drug effectiveness and safety
topic Original Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6735839/
https://www.ncbi.nlm.nih.gov/pubmed/30649201
http://dx.doi.org/10.1093/bioinformatics/btz023
work_keys_str_mv AT simonovskyeyal largescaleanalysisofhumangeneexpressionvariabilityassociateshighlyvariabledrugtargetswithlowerdrugeffectivenessandsafety
AT schusterronen largescaleanalysisofhumangeneexpressionvariabilityassociateshighlyvariabledrugtargetswithlowerdrugeffectivenessandsafety
AT yegerlotemesti largescaleanalysisofhumangeneexpressionvariabilityassociateshighlyvariabledrugtargetswithlowerdrugeffectivenessandsafety